[Clinical characteristics and prognosis analysis of 108 cases of recurrent nasopharyngeal carcinoma from a single center]
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Age, chemotherapy, and specific biomarkers like D-dimer and IL-10 significantly impact nasopharyngeal carcinoma recurrence survival. These factors can guide prognosis and treatment strategies for recurrent NPC patients.
Area Of Science
- Oncology
- Cancer Research
- Clinical Medicine
Context
- Recurrent nasopharyngeal carcinoma (NPC) presents significant challenges in patient management and prognosis.
- Identifying reliable prognostic factors is crucial for tailoring treatment strategies and improving survival outcomes.
- Previous research has explored various clinicopathologic features, but a comprehensive analysis of recurrent NPC is needed.
Purpose
- To conduct a retrospective analysis correlating clinicopathologic features and related indexes with prognosis in patients with recurrent nasopharyngeal carcinoma (NPC).
- To identify independent risk factors influencing the overall survival of patients diagnosed with recurrent NPC.
- To explore potential new biomarkers for predicting prognosis in recurrent NPC.
Summary
- A study of 108 recurrent NPC patients revealed a median survival of 54 months. Age over 46 years was associated with significantly better 5-year overall survival (50.2% vs. 27.9%).
- Univariate analysis identified age, chemotherapy regimen, EBV early antigen IgA, plasma D-dimer, glycan antigen-125, IL-10, and IL-4 as significant factors. Multifactorial analysis confirmed age, chemotherapy regimen, EBV early antigen IgA, plasma D-dimer, glycan antigen-125, and IL-10 as independent prognostic influences.
- Chemotherapy regimens significantly affect prognosis. Elevated plasma D-dimer, glycan antigen 125, and IL-10 levels are identified as potential independent prognostic factors for recurrent NPC.
Impact
- The findings highlight the prognostic significance of specific biomarkers (D-dimer, CA125, IL-10) and patient age in recurrent nasopharyngeal carcinoma.
- Chemotherapy regimen choice is a critical factor influencing survival outcomes in recurrent NPC.
- These identified factors may serve as valuable biomarkers for predicting prognosis and guiding clinical decision-making in recurrent NPC management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...